Telesis Bio Inc. (TBIO) vs Vivos Therapeutics, Inc. (VVOS)
Telesis Bio Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Telesis Bio Inc. and Vivos Therapeutics, Inc. are of similar size ($5.3M and $4.9M). Vivos Therapeutics, Inc. grew revenue faster over the last twelve months: 45.2% against −38.1%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −287.9%) and the lower return on invested capital (−592.7% vs 0.00%). Across the 16 metrics below, Vivos Therapeutics, Inc. leads on 9 and Telesis Bio Inc. on 7.
Valuation
Profitability
| Metric | TBIO | VVOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 45.62% | 61.89% | 56.01% |
| Operating margin | (265.73%) | (107.89%) | (15.03%) |
| Net margin | (287.90%) | (121.79%) | (20.40%) |
| Free cash flow margin | (143.25%) | (90.97%) | (7.24%) |
| Return on equity | 1,013.88% | 10,022.05% | (15.32%) |
| Return on assets | (73.87%) | (101.46%) | (19.72%) |
| Return on invested capital | 0.00% | (592.70%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack